Rovituso, Damiano M.
Duffy, Cathrina E.
Schroeter, Michael
Kaiser, Claudia C.
Kleinschnitz, Christoph
Bayas, Antonios
Elsner, Rebecca
Kuerten, Stefanie
Article History
Received: 2 March 2015
Accepted: 21 August 2015
First Online: 21 September 2015
Competing interests
: DMR has received a grant for participation in a scientific meeting from TEVA in addition to personal compensation from Novartis. MS has received personal and/or institutional compensation from Almirall, Baxter, Bayer HealthCare, Boehringer Ingelheim, Biogen Idec, CSL Behring, Grifols, Merck Serono, Novartis, Sanofi-Genzyme and TEVA. CCK has received grant support from TEVA, Bayer Vital and Novartis as well as personal and institutional compensation from Merck, Novartis, Biogen Idec. CD reports no potential conflicts of interest. CK has received personal and/or institutional compensation from Bayer HealthCare, Biotronik, Boehringer Ingelheim, Biogen Idec, Eisai, Merck Serono, Novartis, Pfizer, Sanofi-Genzyme, Siemens and TEVA. AB has received personal compensation from Merck Serono, Biogen Idec, Bayer Vital, Novartis, Sanofi/Genzyme and TEVA and received grants for congress trips and participation from Sanofi/Genzyme, Biogen Idec and Merck Serono. RE reports no potential conflicts of interest. SK has received grant support from TEVA, Bayer Vital, Novartis and Sanofi/Genzyme, travel support from TEVA and Sanofi/Genzyme and personal compensations from TEVA and Novartis.